Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06667908
Title A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) (CONVERGE)
Acronym CONVERGE
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johnson & Johnson Enterprise Innovation Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Yale University New Haven Connecticut 06519 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field